89.67

0.61% -0.7894

Globus Medical Inc (GMED)

Overview News Price History Option Chain Financials Discussions Forecast

Globus Medical Inc stock is traded at $89.67, with a volume of 126.64K. It is down -0.61% in the last 24 hours and up +2.75% over the past month. Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

Previous Close:

$90.46

Open:

$89.16

24h Volume:

126.64K

Relative Volume:

0.09

Market Cap:

$12.09B

Revenue:

$2.51B

Net Income/Loss:

$185.56M

P/E Ratio:

66.92

EPS:

1.34

Net Cash Flow:

$517.59M

1W Performance:

-7.04%

1M Performance:

+2.75%

6M Performance:

+48.36%

1Y Performance:

+14.06%

1-Day Range:

$88.64

$90.88

1-Week Range:

$88.64

$96.00

52-Week Range:

$51.79

$101.40

Globus Medical Inc Stock (GMED) Company Profile

Name

Globus Medical Inc

Sector

Healthcare (1111)

Industry

Medical Devices (138)

Phone

610-930-1800

Address

2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA

Employee

6,000

Twitter

@GlobusMedical

Next Earnings Date

2026-02-24

Latest SEC Filings

GMED's Discussions on Twitter

Compare GMED vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
GMED Globus Medical Inc	89.42	12.23B	2.51B	185.56M	517.59M	1.34
ABT Abbott Laboratories	110.94	196.53B	44.33B	6.50B	7.40B	3.717
SYK Stryker Corp	372.62	146.14B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	92.88	122.74B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	71.01	107.15B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	84.17	49.45B	6.07B	1.06B	1.34B	1.8063

Globus Medical Inc Stock (GMED) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-30-26	Upgrade	Needham	Hold → Buy
Jan-27-26	Initiated	TD Cowen	Buy
Nov-07-25	Upgrade	BofA Securities	Neutral → Buy
Nov-07-25	Upgrade	Truist	Hold → Buy
Oct-28-25	Resumed	Stifel	Hold
May-27-25	Downgrade	BTIG Research	Buy → Neutral
Jan-10-25	Upgrade	BofA Securities	Underperform → Neutral
Dec-02-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Aug-07-24	Upgrade	Wells Fargo	Equal Weight → Overweight
May-20-24	Upgrade	Piper Sandler	Neutral → Overweight
Mar-18-24	Upgrade	BTIG Research	Neutral → Buy
Oct-20-23	Initiated	ROTH MKM	Buy
Sep-19-23	Upgrade	Stifel	Hold → Buy
Mar-30-23	Upgrade	Canaccord Genuity	Hold → Buy
Feb-13-23	Downgrade	BofA Securities	Buy → Underperform
Feb-10-23	Downgrade	BTIG Research	Buy → Neutral
Feb-10-23	Downgrade	Loop Capital	Buy → Hold
Feb-10-23	Downgrade	Needham	Buy → Hold
Feb-10-23	Downgrade	Truist	Buy → Hold
Feb-10-23	Downgrade	Wells Fargo	Overweight → Equal Weight
Oct-18-22	Initiated	Barclays	Overweight
Oct-12-22	Initiated	Jefferies	Buy
Apr-13-22	Resumed	Truist	Buy
Mar-28-22	Initiated	Wells Fargo	Overweight
Jan-04-22	Upgrade	Piper Sandler	Neutral → Overweight
Dec-13-21	Upgrade	BofA Securities	Underperform → Buy
Dec-10-21	Initiated	RBC Capital Mkts	Outperform
Oct-29-21	Initiated	Loop Capital	Buy
Feb-18-21	Resumed	Needham	Buy
Dec-08-20	Initiated	Citigroup	Buy
Oct-20-20	Initiated	Stifel	Hold
Aug-06-20	Reiterated	Needham	Buy
Aug-06-20	Upgrade	Northland Capital	Market Perform → Outperform
Jul-21-20	Initiated	Northland Capital	Market Perform
Jul-06-20	Downgrade	Piper Sandler	Overweight → Neutral
May-08-20	Reiterated	Needham	Buy
Mar-18-20	Upgrade	BTIG Research	Neutral → Buy
Jan-08-20	Initiated	SunTrust	Buy
Dec-12-19	Upgrade	Wells Fargo	Market Perform → Outperform
Aug-02-19	Reiterated	Needham	Buy
May-24-19	Downgrade	Wells Fargo	Outperform → Market Perform
May-03-19	Reiterated	Needham	Buy
Feb-28-19	Upgrade	UBS	Neutral → Buy
Jan-02-19	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Aug-02-18	Reiterated	Needham	Buy
Jun-27-18	Downgrade	BofA/Merrill	Neutral → Underperform
Jun-01-18	Initiated	Cantor Fitzgerald	Overweight
May-03-18	Reiterated	Needham	Buy
Apr-04-18	Upgrade	Needham	Hold → Buy

View All

Globus Medical Inc Stock (GMED) Latest News

10:04 AM

Globus Medical (NYSE:GMED) Stock Rating Upgraded by Zacks Research - MarketBeat

10:04 AM

08:52 AM

Is This the Right Time to Add Globus Medical Stock to Your Portfolio? - TradingView

08:52 AM

07:00 AM

GW&K Investment Management LLC Sells 72,271 Shares of Globus Medical, Inc. $GMED - MarketBeat

07:00 AM

05:00 AM

Burgundy Asset Management Ltd. Has $212.05 Million Stake in Globus Medical, Inc. $GMED - MarketBeat

05:00 AM

Mar 04, 2026

Globus Medical: Is the Post-Deal Integration Machine Turning NuVasive and Nevro Into a Real Musculoskeletal Powerhouse? - Smartkarma

Mar 04, 2026

Globus Medical Reports Fourth-Quarter and Full-Year 2025 Results - MyChesCo

Mar 04, 2026

Globus Medical (GMED) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Finance

Mar 04, 2026

Mar 03, 2026

Segall Bryant & Hamill LLC Buys 13,583 Shares of Globus Medical, Inc. $GMED - MarketBeat

Mar 03, 2026

Champlain Investment Partners LLC Acquires 365,418 Shares of Globus Medical, Inc. $GMED - MarketBeat

Mar 03, 2026

Mar 02, 2026